반응식
[NH2:1][CH2:2][C@H:3]1[C@@H:8]([CH3:9])[CH2:7][CH2:6][CH2:5][N:4]1[C:10]([C:12]1[N:13]=[C:14]([CH3:24])[S:15][C:16]=1[C:17]1[CH:22]=[CH:21][C:20]([F:23])=[CH:19][CH:18]=1)=[O:11].[CH3:25][O:26][C:27]1[CH:32]=[CH:31][N:30]=[C:29](Cl)[N:28]=1.CCN(C(C)C)C(C)C>C(O)(C)C>[F:23][C:20]1[CH:19]=[CH:18][C:17]([C:16]2[S:15][C:14]([CH3:24])=[N:13][C:12]=2[C:10]([N:4]2[CH2:5][CH2:6][CH2:7][C@H:8]([CH3:9])[C@@H:3]2[CH2:2][NH:1][C:29]2[N:28]=[C:27]([O:26][CH3:25])[CH:32]=[CH:31][N:30]=2)=[O:11])=[CH:22][CH:21]=1참가 물질
5
반응물 3
생성물 1
시약·촉매·용매 1
반응 조건
- 온도
- 110 °C
실험 절차
A mixture of rac-cis-(2-(aminomethyl)-3-methylpiperidin-1-yl)(5-(4-fluorophenyl)-2-methylthiazol-4-yl)methanone, 4-methoxy-2-chloropyrimidine, and DIPEA in isopropanol was stirred at 110° C. for 18 h. The reaction was cooled and concentrated in vacuo. The crude reaction mixture was purified by reverse-phase preparative HPLC to afford the title compound. MS (ESI) 456.02 (M+H).
후처리
- temperatureThe reaction was cooled
- concentrationconcentrated in vacuo
- customThe crude reaction mixture
- customwas purified by reverse-phase preparative HPLC
출처 및 근거
- ORD 기록
- ord-1d3c11367f7b4f488f0b06069359f832
- 출처 데이터셋
- uspto-grants-2016_09
- 특허 번호
- US09440982B2
연결된 노트
불러오는 중…